1.710USD+0.59%Mkt Cap: 70.31M USDP/E: —Last update: 2026-06-01
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: t…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap70.31M USD
Enterprise Value65.60M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.01M USD
Revenue/Share—
Last Price1.710 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees44
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.57
PEG—
EV/EBITDA-7.68
EV/Revenue—
P/S—
P/B-2.00
EPS (TTM)-0.25
EPS (Forward)-0.47
52W Range
1.17524% of range3.440
52W High3.440 USD
52W Low1.175 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE3.13%
ROA-3.88%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.77M USD
CapEx (TTM)50.00K USD
FCF Margin—
FCF Yield17.79%
Net Debt-7.62M USD
Net Debt/EBITDA0.89
Balance Sheet
Debt/Equity-0.01
Current Ratio1.09
Quick Ratio0.64
Book Value/Sh-0.8390 USD
Cash/Share0.1910 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.41.12M
Float31.69M
Insiders14.26%
Institutions14.55%
Short Interest
Short Ratio186.6d
Short % Float6.40%
Short % Out.5.31%
Shares Short2.18M
Short (prev mo.)2.19M
Technical
SMA 501.597 (+7.1%)
SMA 2001.722 (-0.7%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)19.66K
Avg Vol (10d)34.27K
Technical Indicators
RSI (14)59.0
MACD0.0161
MACD Signal-0.0242
MACD Hist.+0.0403
BB Upper1.716 USD
BB Middle1.493 USD
BB Lower1.271 USD
BB Width29.83%
ATR (14)0.1767 USD
Vol Ratio (20d)0.65x